NCT07369505 2026-01-27
Sapu003 in Advanced mTOR-sensitive Solid Tumors
SAPU NANO (US) LLC
Phase 1 Recruiting
SAPU NANO (US) LLC
GRIN Therapeutics, Inc.
GRIN Therapeutics, Inc.
Neurim Pharmaceuticals Ltd.
The University of Texas Health Science Center, Houston